Targeting Fibrosis in Kidney, Bone Marrow, and Urological Diseases
Discuss Means of Detecting and Measuring Pathologic Fibrosis in Humans
Questions to be answered
Can we differentiate between pathologic fibrosis and that of normal aging?
Does fibrosis correlate with organ dysfunction?
Does imaging of fibrosis correlate with organ dysfunction, recovery, and regression?
What novel biomarkers or technologies should be pursued to detect and measure pathologic fibrosis?
Tamara Bavendam, Terry Bishop, Ed Doo, Deborah Hoshizaki, Chris Ketchum, Ziya Kirkali, Maren Laughlin, Tracy Rankin, and Krystyna Rys-Sikora
Natcher Conference Center
National Institutes of Health
Bethesda , MD 20892
Michael F. Flessner, M.D., Ph.D.
John Hare, M.S., CMP, CGMP
The Scientific Consulting Group, Inc.